Preventing MH - An Anesthesia Protocol

This protocol is intended as a guide for anesthesia practioners and other health care professionals to be prepared to recognize, treat and prevent malignant hyperthermia (MH).

ROUTINE PRE-OPERATIVE QUESTIONING

All patients about to undergo general anesthesia should be asked these specific questions as part of a medical history:

INTRA-OPERATIVE PREPAREDNESS

The following precautions should be taken in order to detect MH in its early stages, when it is usually amenable to treatment without sequelae:

Planning Ahead:


During Surgery


TREATING THE KNOWN OR SUSPECTED MH-SUSCEPTIBLE PATIENT

Pre-operative Preparations:

Dantrolene Prophylaxis:

NOTE: Dantrolene can worsen muscle weakness in patients with muscle disease and should be used with caution. For procedures with local anesthesia only, dantrolene prophylaxis may be omitted.

Intra-operative Considerations

Post-operative Procedure


MHAUS HOTLINE

Names and phone numbers of on-call anesthesiologists available to consult in MH emergencies may be obtained 24 hours a day through:

MEDIC ALERT FOUNDATION INTERNATIONAL

(209) 634-4917 Ask for Index Zero



This brochure was written and produced by the MALIGNANT HYPERTHERMIA ASSOCIATION OF THE UNITED STATES (MHAUS).

MHAUS serves MH-susceptible individuals and medical professionals. MHAUS is a non-profit organization under IRS code 501(c)(3). Its services are provided free. It operates solely on contributed funds. All contributions are tax-deductible and should be sent to:

MHAUS
PO Box 1069
Sherburne, NY 13460-1069
(607) 674-7901

This protocol may not apply to every patient and must of necessity be altered according to specific patient needs.